期刊文献+
共找到13,133篇文章
< 1 2 250 >
每页显示 20 50 100
Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferonβ 1a
1
作者 Eckart Schott Friedemann Paul +4 位作者 Jens T Wuerfel Frauke Zipp Birgit Rudolph Bertram Wiedenmann Daniel C Baumgart 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第26期3638-3640,共3页
To alert clinicians to a potential novel adverse drug effect of interferonβ la, we herein report a patient with relapsing-remitting multiple sclerosis who developed ulcerative colitis following treatment with interfe... To alert clinicians to a potential novel adverse drug effect of interferonβ la, we herein report a patient with relapsing-remitting multiple sclerosis who developed ulcerative colitis following treatment with interferonβ la. Ulcerative colitis persisted despite discontinuation of interferonβ la treatment and switching the patient to glatiramer acetate. Tacrolimus (FK506), 6-mercaptopurine, and prednisolone were required to induce remission. Both ulcerative colitis and multiple sclerosis were eventually well controlled using this regimen. Our report underscores that caution should be exercised when prescribing immunostimulatory agents in patients with inflammatory bowel disease (IBD) and challenges current efforts to stimulate innate immunity as a novel therapeutic concept for IBD. 展开更多
关键词 Ulcerative colitis interferonβ la TACROLIMUS Innate immunity Multiple sclerosis Adverse drug effects
暂未订购
The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson's disease
2
作者 Shengyang Zhou Ting Li +8 位作者 Wei Zhang Jian Wu Hui Hong Wei Quan Xinyu Qiao Chun Cui Chenmeng Qiao Weijiang Zhao Yanqin Shen 《Neural Regeneration Research》 SCIE CAS 2025年第8期2361-2372,共12页
Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report... Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report that interferon regulatory factor 7 is markedly up-regulated in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease and co-localizes with microglial cells.Both the selective cyclic guanosine monophosphate adenosine monophosphate synthase inhibitor RU.521 and the stimulator of interferon genes inhibitor H151 effectively suppressed interferon regulatory factor 7 activation in BV2 microglia exposed to 1-methyl-4-phenylpyridinium and inhibited transformation of mouse BV2 microglia into the neurotoxic M1 phenotype.In addition,si RNA-mediated knockdown of interferon regulatory factor 7 expression in BV2 microglia reduced the expression of inducible nitric oxide synthase,tumor necrosis factorα,CD16,CD32,and CD86 and increased the expression of the anti-inflammatory markers ARG1 and YM1.Taken together,our findings indicate that the cyclic guanosine monophosphate adenosine monophosphate synthase-stimulator of interferon genes-interferon regulatory factor 7 pathway plays a crucial role in the pathogenesis of Parkinson's disease. 展开更多
关键词 cyclic guanosine monophosphate adenosine monophosphate synthase H151 interferon regulatory factor 7 M1 phenotype neurodegenerative disease NEUROINFLAMMATION Parkinson’s disease RU521 STING type I interferon
暂未订购
Brain endothelial cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway in aging and neurodegeneration
3
作者 Bryan Sun Lulin Li Jian Luo 《Neural Regeneration Research》 SCIE CAS 2025年第7期2005-2007,共3页
The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial ce... The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial cells,emerging research suggests that cGAS-STING signaling may play a critical role in cerebral vasculature,particularly in brain endothelial cells.Therefore,studying the role 7of inflammation caused by the cGAS-STING pathway in brain endothelial cells could provide a more comprehensive understanding of neuroinflammatory disease and new avenues for therapeutic interventions.Here,we review the multifaceted role of global cGAS-STING signaling in various neurological and neuroinflammatory diseases and the potential contribution of cGAS-STING in brain endothelial cells. 展开更多
关键词 STIMULATOR interferon inflammation
暂未订购
Bidirectional regulation of the cyclic guanosine monophosphateadenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma
4
作者 Ai-Yu Nie Zhong-Hui Xiao +4 位作者 Jia-Li Deng Na Li Li-Yuan Hao Sheng-Hao Li Xiao-Yu Hu 《World Journal of Gastrointestinal Oncology》 2025年第2期246-261,共16页
BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS... BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)activates the stimulator of interferon gene(STING)signaling pathway as a crucial immune response pathway in the cytoplasm,which detects cytoplasmic DNA to regulate innate and adaptive immune responses.As a potential therapeutic target,cGASSTING pathway markedly inhibits tumor cell proliferation and metastasis,with its activation being particularly relevant in HCC.However,prolonged pathway activation may lead to an immunosuppressive tumor microenvironment,which fostering the invasion or metastasis of liver tumor cells.AIM To investigate the dual-regulation mechanism of cGAS-STING in HCC.METHODS This review was conducted according to the PRISMA guidelines.The study conducted a comprehensive search for articles related to HCC on PubMed and Web of Science databases.Through rigorous screening and meticulous analysis of the retrieved literature,the research aimed to summarize and elucidate the impact of the cGAS-STING pathway on HCC tumors.RESULTS All authors collaboratively selected studies for inclusion,extracted data,and the initial search of online databases yielded 1445 studies.After removing duplicates,remaining 964 records were screened.Ultimately,55 articles met the inclusion criteria and were included in this review.CONCLUSION Acute inflammation can have a few inhibitory effects on cancer,while chronic inflammation generally promotes its progression.Extended cGAS-STING pathway activation will result in a suppressive tumor microenvironment. 展开更多
关键词 Hepatocellular carcinoma Cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene interferon genes The metastasis of a tumor IMMUNOLOGY
暂未订购
Ropeginterferonα-2b治疗骨髓增殖性肿瘤的研究进展
5
作者 屠玲榕 黄健 《中国实验血液学杂志》 北大核心 2025年第1期306-310,共5页
Ropeginterferonα-2b是新上市的一种长效聚乙二醇脯氨酸α干扰素,是第一种专门批准用于治疗真性红细胞增多症的干扰素,临床试验和经验发现其可以诱导骨髓增殖性肿瘤患者血液学缓解,控制疾病相关症状,降低JAK2V617F基因突变负荷。与聚... Ropeginterferonα-2b是新上市的一种长效聚乙二醇脯氨酸α干扰素,是第一种专门批准用于治疗真性红细胞增多症的干扰素,临床试验和经验发现其可以诱导骨髓增殖性肿瘤患者血液学缓解,控制疾病相关症状,降低JAK2V617F基因突变负荷。与聚乙二醇干扰素α和羟基脲相比,其药物不良反应发生率和严重程度较低,且给药间隔时间更长,部分低危真性红细胞增多症和骨髓纤维化患者也能从中获益。本文就Ropeginterferonα-2b在骨髓增殖性肿瘤中的最新研究进展作一综述。 展开更多
关键词 骨髓增殖性肿瘤 Ropeginterferonα-2b Α干扰素 治疗
原文传递
Jianpi Yifei Tongluo recipe(健脾益肺通络方剂)attenuates inflammation by promoting the expression of interferon regulatory factor 4 in the rat model of chronic obstructive pulmonary disease
6
作者 WANG Wei LONG Qi +1 位作者 FU Ling WU Haiqiao 《Journal of Traditional Chinese Medicine》 2025年第5期1048-1058,共11页
OBJECTIVE:To examine the effects of the Jianpi Yifei Tongluo recipe(健脾益肺通络方剂,JYTR)on chronic obstructive pulmonary disease(COPD)within an animal model and to elucidate its anti-inflammatory mechanisms.METHODS:... OBJECTIVE:To examine the effects of the Jianpi Yifei Tongluo recipe(健脾益肺通络方剂,JYTR)on chronic obstructive pulmonary disease(COPD)within an animal model and to elucidate its anti-inflammatory mechanisms.METHODS:In this study,we utilized cigarette smoke(CS)exposure and lipopolysaccharide(LPS)-induced models of COPD in rats to evaluate the effects of the JYTR on airway inflammation.Sprague-Dawley rats were randomly assigned to various groups:control,model,budesonide,synbiotics,and low,medium,and high JYTR.Pulmonary function was gauged using an animal volumetric tracer.Pathological alterations in lung tissue were examined under a light microscope.To ascertain cytokine production,we conducted enzyme-linked immunosorbent assay tests,and we employed Western blotting to measure the expression levels of interferon regulatory factor 4(IRF4),arginase 1(Arg1),inducible nitric oxide synthase(iNOS),nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,alpha(IKB-α),and P65.RESULTS:Compared to the control group,rats in the COPD model group exhibited significantly compromised pulmonary function and severe inflammatory pathology in the lungs.Treatment with budesonide,synbiotics,and the JYTR markedly improved pulmonary function and diminished the production of inflammatory cytokines transforming growth factor-beta(TGF-β),tumor necrosis factor-alpha(TNF-α),and interleukin-6(IL-6).These improvements were particularly notable in the budesonide group and the high-dose JYTR group.Additionally,the JYTR increased the expression of IRF4 and upregulated the protein expression of Arg1,while concurrently downregulating the protein expression of iNOS,phosphorylated IKB-α,and phosphorylated P65.CONCLUSION:Our current study reveals that JYTR can mitigate inflammatory lung injury,enhance lung function,and lower levels of inflammatory cytokines induced by CS or LPS exposure in COPD model rats.The mechanism behind its anti-inflammatory effect likely involves the regulation of IRF4 expression and M2 polarization through the nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway. 展开更多
关键词 cigarette smoking INFLAMMATION pulmonary disease chronic obstructive interferon regulatory factors Jianpi Yifei Tongluo recipe
原文传递
Association of interferon regulatory factor 8 dysregulation with dry eye in Sjögren’s syndrome
7
作者 Jiao Wang Guang-Hong Chu +4 位作者 Zi-Huan Wang Xiao-Yu Cai Si-Yuan Shi Qi-Ping Qing Qi Zhang 《International Journal of Ophthalmology(English edition)》 2025年第8期1456-1463,共8页
AIM:To investigate the expression of interferon regulatory factors(IRFs)in peripheral blood mononuclear cells(PBMCs)of patients with Sjögren’s syndrome-related dry eye(SSDE)and to explore their correlation with ... AIM:To investigate the expression of interferon regulatory factors(IRFs)in peripheral blood mononuclear cells(PBMCs)of patients with Sjögren’s syndrome-related dry eye(SSDE)and to explore their correlation with clinical features,dendritic cell activation,and serological indicators.METHODS:A total of 53 SSDE patients and 62 non-Sjögren’s syndrome dry eye(NSSDE)patients were enrolled.Demographic and clinical data were collected,and comprehensive ophthalmic examinations were performed,including the ocular surface disease index(OSDI)questionnaires,Schirmer I test(SIT),tear break-up time(TBUT),corneal fluorescein staining score(CFS),and in vivo confocal microscopy(IVCM).PBMCs were isolated,and IRFs expression levels were analyzed using Western blotting(WB)and quantitative real-time polymerase chain reaction(qRT-PCR).Serological indicators,including antinuclear antibodies(ANA)and anti-Ro60,anti-Ro52,and anti-La autoantibodies,were detected.Statistical analyses evaluated correlations between IRFs expression and clinical parameters.RESULTS:Compared to NSSDE,the relative mRNA and protein expression of the IRF-8 was significantly upregulated in patients with SSDE(P<0.001),whereas no significant differences were observed in IRF-1,IRF-3,IRF-5,and IRF-7(P=0.12,P=0.10,P=0.66,P=0.96).Correlation analysis revealed that IRF-8 expression was positively associated with CFS and OSDI scores(r=0.57,r=0.38,both P<0.05).Moreover,IRF-8 expression correlated with corneal dendritic cell(DC)density and size,and the number of dendrites(r=0.43,r=0.40,r=0.65,all P<0.05).IRF-8 expression was significantly elevated in patients positive for anti-Ro60,anti-Ro52 and anti-La autoantibodies(P<0.05).CONCLUSION:In SSDE,IRF-8 is upregulated and associated with clinical features,DC activation,and serological indicators.These findings suggest that IRF-8 plays a critical role in SSDE pathogenesis and may serve as a potential therapeutic target for diagnosis and treatment. 展开更多
关键词 interferon regulatory factors Sjögren’s syndrome dry eye
原文传递
Pseudorabies virus VHS protein abrogates interferon responses by blocking NF-κB and IRF3 nuclear translocation 被引量:2
8
作者 Zhenfang Yan Jiayu Yue +9 位作者 Yaxin Zhang Zhengyang Hou Dianyu Li Yanmei Yang Xiangrong Li Adi Idris Huixia Li Shasha Li Jingying Xie Ruofei Feng 《Virologica Sinica》 SCIE CAS CSCD 2024年第4期587-599,共13页
Herpesviruses antagonize host antiviral responses through a myriad of molecular strategies culminating in the death of the host cells.Pseudorabies virus(PRV)is a significant veterinary pathogen in pigs,causing neurolo... Herpesviruses antagonize host antiviral responses through a myriad of molecular strategies culminating in the death of the host cells.Pseudorabies virus(PRV)is a significant veterinary pathogen in pigs,causing neurological sequalae that ultimately lead to the animal's demise.PRV is known to trigger apoptotic cell death during the late stages of infection.The virion host shutdown protein(VHS)encoded by UL41 plays a crucial role in the PRV infection process.In this study,we demonstrate that UL41 inhibits PRV-induced activation of inflammatory cytokine and negatively regulates the cGAS-STING-mediated antiviral activity by targeting IRF3,thereby inhibiting the translocation and phosphorylation of IRF3.Notably,mutating the conserved amino acid sites(E192,D194,and D195)in the RNase domain of UL41 or knocking down UL41 inhibits the immune evasion of PRV,suggesting that UL41 may play a crucial role in PRV's evasion of the host immune response during infection.These results enhance our understanding of how PRV structural proteins assist the virus in evading the host immune response. 展开更多
关键词 Pseudorabies virus(PRV) UL41 IRF3 interferon cGAS-STING
原文传递
Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis 被引量:3
9
作者 Hongzhen Chen Xuekun Fu +15 位作者 Xiaohao Wu Junyi Zhao Fang Qiu Zhenghong Wang Zhuqian Wang Xinxin Chen Duoli Xie Jie Huang Junyu Fan Xu Yang Yi Song Jie Li Dongyi He Guozhi Xiao Aiping Lu Chao Liang 《Bone Research》 SCIE CAS CSCD 2024年第2期421-437,共17页
Rheumatoid arthritis(RA)is an autoimmune disease.Early studies hold an opinion that gut microbiota is environmentally acquired and associated with RA susceptibility.However,accumulating evidence demonstrates that gene... Rheumatoid arthritis(RA)is an autoimmune disease.Early studies hold an opinion that gut microbiota is environmentally acquired and associated with RA susceptibility.However,accumulating evidence demonstrates that genetics also shape the gut microbiota.It is known that some strains of inbred laboratory mice are highly susceptible to collagen-induced arthritis(CIA),while the others are resistant to CIA.Here,we show that transplantation of fecal microbiota of CIA-resistant C57BL/6J mice to CIA-susceptible DBA/1J mice confer CIA resistance in DBA/1J mice.C57BL/6J mice and healthy human individuals have enriched B.fragilis than DBA/1J mice and RA patients.Transplantation of B.fragilis prevents CIA in DBA/1J mice.We identify that B.fragilis mainly produces propionate and C57BL/6J mice and healthy human individuals have higher level of propionate.Fibroblast-like synoviocytes(FLSs)in RA are activated to undergo tumor-like transformation.Propionate disrupts HDAC3-FOXK1 interaction to increase acetylation of FOXK1,resulting in reduced FOXK1 stability,blocked interferon signaling and deactivation of RA-FLSs.We treat CIA mice with propionate and show that propionate attenuates CIA.Moreover,a combination of propionate with anti-TNF etanercept synergistically relieves CIA.These results suggest that B.fragilis or propionate could be an alternative or complementary approach to the current therapies. 展开更多
关键词 HDAC3 cytes interferon
暂未订购
Key role of interferon regulatory factor 1(IRF-1)in regulating liver disease:progress and outlook 被引量:1
10
作者 Tao CHEN Shipeng LI +3 位作者 Dewen DENG Weiye ZHANG Jianjun ZHANG Zhongyang SHEN 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2024年第6期451-470,共20页
Interferon regulatory factor 1(IRF-1)is a member of the IRF family.It is the first transcription factor to be identified that could bind to the interferon-stimulated response element(ISRE)on the target gene and displa... Interferon regulatory factor 1(IRF-1)is a member of the IRF family.It is the first transcription factor to be identified that could bind to the interferon-stimulated response element(ISRE)on the target gene and displays crucial roles in the interferoninduced signals and pathways.IRF-1,as an important medium,has all of the advantages of full cell cycle regulation,cell death signaling transduction,and reinforcing immune surveillance,which are well documented.Current studies indicate that IRF-1 is of vital importance to the occurrence and evolution of multifarious liver diseases,including but not limited to inhibiting the replication of the hepatitis virus(A/B/C/E),alleviating the progression of liver fibrosis,and aggravating hepatic ischemiareperfusion injury(HIRI).The tumor suppression of IRF-1 is related to the clinical characteristics of liver cancer patients,which makes it a potential indicator for predicting the prognosis and recurrence of liver cancer;additionally,the latest studies have revealed other effects of IRF-1 such as protection against alcoholic/non-alcoholic fatty liver disease(AFLD/NAFLD),cholangiocarcinoma suppression,and uncommon traits in other liver diseases that had previously received little attention.Intriguingly,several compounds and drugs have featured a protective function in specific liver disease models in which there is significant involvement of the IRF-1 signal.In this paper,we hope to propose a prospective research basis upon which to help decipher translational medicine applications of IRF-1 in liver disease treatment. 展开更多
关键词 interferon regulatory factor(IRF-1) Hepatitis virus Liver fibrosis Hepatic ischemia-reperfusion injury(HIRI) Liver cancer
原文传递
Role of cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes pathway in diabetes and its complications 被引量:1
11
作者 Ming-Wei Fan Jin-Lan Tian +5 位作者 Tan Chen Can Zhang Xin-Ru Liu Zi-Jian Zhao Shu-Hui Zhang Yan Chen 《World Journal of Diabetes》 SCIE 2024年第10期2041-2057,共17页
Diabetes mellitus(DM)is one of the major causes of mortality worldwide,with inflammation being an important factor in its onset and development.This review summarizes the specific mechanisms of the cyclic guanosine mo... Diabetes mellitus(DM)is one of the major causes of mortality worldwide,with inflammation being an important factor in its onset and development.This review summarizes the specific mechanisms of the cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)-stimulator of interferon genes(STING)pathway in mediating inflammatory responses.Furthermore,it compre-hensively presents related research progress and the subsequent involvement of this pathway in the pathogenesis of early-stage DM,diabetic gastroenteropathy,diabetic cardiomyopathy,non-alcoholic fatty liver disease,and other complic-ations.Additionally,the role of cGAS-STING in autonomic dysfunction and intes-tinal dysregulation,which can lead to digestive complications,has been discuss-ed.Altogether,this study provides a comprehensive analysis of the research advances regarding the cGAS-STING pathway-targeted therapeutic agents and the prospects for their application in the precision treatment of DM. 展开更多
关键词 Cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes Diabetes mellitus Inflammation Glycolipid metabolism Diabetes gastroenteropathy Nonalcoholic fatty liver disease Diabetes cardiovascular disease Diabetes nephropathy
暂未订购
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
12
作者 YANG Liu WANG Shi Yu +13 位作者 JIANG Ting Ting DENG Wen CHANG Min WU Shu Ling CAO Wei Hua LU Yao SHEN Ge LIU Ru Yu GAO Yuan Jiao XU Meng Jiao HU Lei Ping ZHANG Lu XIE Yao LI Ming Hui 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2024年第3期303-314,共12页
Objective This study aimed to evaluate whether the onset of the plateau phase of slow hepatitis B surface antigen decline in patients with chronic hepatitis B treated with intermittent interferon therapy is related to... Objective This study aimed to evaluate whether the onset of the plateau phase of slow hepatitis B surface antigen decline in patients with chronic hepatitis B treated with intermittent interferon therapy is related to the frequency of dendritic cell subsets and expression of the costimulatory molecules CD40,CD80,CD83,and CD86.Method This was a cross-sectional study in which patients were divided into a natural history group(namely NH group),a long-term oral nucleoside analogs treatment group(namely NA group),and a plateau-arriving group(namely P group).The percentage of plasmacytoid dendritic cell and myeloid dendritic cell subsets in peripheral blood lymphocytes and monocytes and the mean fluorescence intensity of their surface costimulatory molecules were detected using a flow cytometer.Results In total,143 patients were enrolled(NH group,n=49;NA group,n=47;P group,n=47).The results demonstrated that CD141/CD1c double negative myeloid dendritic cell(DNmDC)/lymphocytes and monocytes(%)in P group(0.041[0.024,0.069])was significantly lower than that in NH group(0.270[0.135,0.407])and NA group(0.273[0.150,0.443]),and CD86 mean fluorescence intensity of DNmDCs in P group(1832.0[1484.0,2793.0])was significantly lower than that in NH group(4316.0[2958.0,5169.0])and NA group(3299.0[2534.0,4371.0]),Adjusted P all<0.001.Conclusion Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B. 展开更多
关键词 CHB Dendritic Cells Intermittent interferon Therapy Plateau Phase
暂未订购
Expression level of interferon-stimulated genes PKR,OAS1,MX1,and ISG15 in peripheral blood mononuclear cells of COVID-19 patients:A retrospective study
13
作者 Elham Jafari Maskouni Samaneh Abbasi +4 位作者 Elham Mousavi Zahra Najafimemar Ali Mohammad Arabzadeh Mehrdad Farrokhnia Saeedeh Ebrahimi 《Journal of Acute Disease》 2024年第3期111-115,共5页
Objective:To explore expression level of interferon-stimulated genes PKR,OAS1,MX1,and ISG15 in peripheral blood mononuclear cells of COVID-19 patients.Methods:In this study,changes in the expression of four interferon... Objective:To explore expression level of interferon-stimulated genes PKR,OAS1,MX1,and ISG15 in peripheral blood mononuclear cells of COVID-19 patients.Methods:In this study,changes in the expression of four interferon-stimulated genes(ISGs),including PKR,OAS1,MX1,and ISG15,in peripheral blood mononuclear cells of 45 COVID-19 patients with different severities were evaluated by real-time PCR method.Results:OAS1,MX1,PKR,and ISG15 were differently expressed in COVID-19 patients with different severity.The results showed that the expression of OAS1,MX1,PKR,and ISG15 genes was significantly(P=0.001)lower in severe patients.Conclusions:Weak and defective IFN response and subsequent disruption of ISGs may be associated with COVID-19 severity. 展开更多
关键词 COVID-19 SARS-CoV-2 interferon ISGs Severe COVID-19 Risk factors interferon signaling
暂未订购
Evaluation of Interferon-Gamma Release Assay Testing and Tuberculin Skin Test for Early Diagnosis of Tuberculosis in Children and Adolescents
14
作者 Yelda Sorguç Miray Çelebi Yılmaz +4 位作者 Yüce Ayhan Yakup Yaman Şener Tulumoğlu Aybüke Akaslan Kara İlker Devrim 《Open Journal of Pediatrics》 2024年第3期558-567,共10页
Background: This study aimed to evaluate the diagnostic value of interferon-γ release assay (IGRA), a sensitive microbiological diagnostic method, in children and adolescents with suspected tuberculosis in a country ... Background: This study aimed to evaluate the diagnostic value of interferon-γ release assay (IGRA), a sensitive microbiological diagnostic method, in children and adolescents with suspected tuberculosis in a country with a high burden of tuberculosis. Method: This study included 581 children and adolescents aged 4 - 19 years who were suspected of having tuberculosis, were latently infected with Mycobacterium tuberculosis, and had received at least one dose of BCG vaccine between April 17, 2019, and February 24, 2021. The study evaluated the TST results of 106 patients who had a positive Quantiferon test and were suspected of having tuberculosis. Results: The study included 581 patients aged between 4 and 19 years. Of these, 106 patients tested positive for the Quantiferon test, while 19 were indeterminate and 456 were negative. The Quantiferon test positivity rate was 18.24%. Among the 106 QFT-Plus-positive cases, 23 patients also tested positive for TST. The difference in distribution was found to be statistically significant. Conclusion: The QFT-Plus test is considered an alternative to TST and other microbiological diagnostic methods for early tuberculosis diagnosis, particularly in children and adolescents. 展开更多
关键词 interferon Gamma Release Assay CHILDREN Tuberculin Test CHILDREN Latent Tuberculosis
暂未订购
核苷类药物联合聚乙二醇干扰素对代偿期乙型肝炎肝硬化患者肝脏硬度值及肝癌发生率的影响 被引量:1
15
作者 闪海霞 孙春伟 +4 位作者 阎道博 夏盼盼 司倩楠 刘正 马慧利 《癌症进展》 2025年第5期552-555,共4页
目的探讨核苷类药物联合聚乙二醇干扰素对代偿期乙型肝炎肝硬化患者肝脏硬度值及肝癌发生率的影响。方法将130例代偿期乙型肝炎肝硬化患者依照治疗方式的不同分为对照组(62例,行核苷类药物治疗)和联合组(68例,行核苷类药物+聚乙二醇干... 目的探讨核苷类药物联合聚乙二醇干扰素对代偿期乙型肝炎肝硬化患者肝脏硬度值及肝癌发生率的影响。方法将130例代偿期乙型肝炎肝硬化患者依照治疗方式的不同分为对照组(62例,行核苷类药物治疗)和联合组(68例,行核苷类药物+聚乙二醇干扰素治疗)。比较两组患者的治疗效果、肝功能指标[丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、乙型肝炎表面抗原(HBsAg)]、乙型肝炎病毒(HBV)-DNA载量、炎症因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、超敏C反应蛋白(hs-CRP)]、肝脏硬度值及肝癌发生率。结果联合组患者总有效率高于对照组,肝癌发生率低于对照组,差异均有统计学意义(P﹤0.05)。治疗后,两组患者ALT、AST、HBsAg水平和HBV-DNA载量均较治疗前降低,且联合组患者ALT、AST、HBsAg水平和HBV-DNA载量均低于对照组,差异均有统计学意义(P﹤0.05)。治疗后,两组患者IL-6、TNF-α、hs-CRP水平和肝脏硬度值均较治疗前降低,且联合组患者IL-6、TNF-α、hs-CRP水平和肝脏硬度值均低于对照组,差异均有统计学意义(P﹤0.05)。结论核苷类药物联合聚乙二醇干扰素治疗能够有效提高代偿期乙型肝炎肝硬化患者的治疗效果,降低肝功能指标、HBV-DNA载量以及炎症因子水平,从而改善肝脏硬度值,并且降低肝癌发生率,值得在临床上应用。 展开更多
关键词 核苷类药物 聚乙二醇干扰素 代偿期乙型肝炎肝硬化 肝癌
暂未订购
安寐丹调控cGAS/STING信号通路介导免疫炎症改善失眠大鼠学习记忆机制 被引量:1
16
作者 徐波 叶子靖 +1 位作者 王平 程静 《中国实验方剂学杂志》 北大核心 2025年第10期27-35,共9页
目的:探讨安寐丹通过调节环鸟苷酸-腺苷酸合成酶(cGAS)/干扰素基因刺激蛋白(STING)信号通路影响免疫炎症,进而改善失眠大鼠学习记忆功能的机制。方法:60只SD大鼠随机分为空白组,模型组,苏沃雷生组(30 mg·kg^(-1)),安寐丹低、中、... 目的:探讨安寐丹通过调节环鸟苷酸-腺苷酸合成酶(cGAS)/干扰素基因刺激蛋白(STING)信号通路影响免疫炎症,进而改善失眠大鼠学习记忆功能的机制。方法:60只SD大鼠随机分为空白组,模型组,苏沃雷生组(30 mg·kg^(-1)),安寐丹低、中、高剂量组(4.55、9.09、18.18 g·kg^(-1)),每组10只;腹腔注射对氯苯丙氨酸(PCPA)构建失眠大鼠模型,给予对应剂量的安寐丹水煎液与生理盐水灌胃28 d;Morris水迷宫、新物体识别检测学习记忆功能;苏木素-伊红(HE)染色和尼氏(Nissl)染色观察海马细胞形态;酶联免疫吸附测定法(ELISA)检测血清白细胞介素-1(IL-1)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、白细胞介素-12(IL-12)、白细胞介素-18(IL-18)、肿瘤坏死因子-α(TNF-α)含量;蛋白免疫印迹法(Westernblot)与实时荧光定量聚合酶链式反应(Real-time PCR)检测海马cGAS、STING蛋白和mRNA相对表达量。结果:与空白组比较,模型组5-羟色胺(5-HT)含量显著降低(P<0.01);上平台潜伏期和总路程明显延长(P<0.05,P<0.01),目标象限驻留时间、穿越平台次数显著减少(P<0.01),新物体相对识别指数显著降低(P<0.01);海马神经元形态、排列松散紊乱,胞内尼氏体数量减少;IL-1、IL-1β、IL-6、IL-8、IL-12、IL-18、TNF-α和cGAS、STING通路蛋白及mRNA相对表达量显著上调(P<0.01)。与模型组比较,安寐丹高剂量组上平台潜伏期明显缩短(P<0.05),安寐丹中、高剂量组和苏沃雷生组目标象限驻留时间、穿越平台次数显著增加(P<0.01),各给药组总路程显著缩短(P<0.01),新物体相对识别指数显著上升(P<0.01),海马神经元排列稍紧密整齐,胞内尼氏体数量增加;安寐丹中、高剂量组IL-1、IL-1β、IL-6、IL-8、IL-12、IL-18、TNF-α和cGAS蛋白及mRNA表达明显下调(P<0.05,P<0.01)。结论:安寐丹改善失眠大鼠学习记忆可能与cGAS/STING信号通路抑制免疫炎症相关。 展开更多
关键词 失眠 免疫炎症 安寐丹 学习记忆 环鸟苷酸-腺苷酸合成酶(cGAS)/干扰素基因刺激蛋白(STING) 信号通路
原文传递
干扰素调节因子4参与B/浆细胞肿瘤发生发展的研究进展 被引量:1
17
作者 陈静 唐文娇 +1 位作者 张丽 潘崚 《华西医学》 2025年第2期324-329,共6页
干扰素调节因子4(interferon regulatory factor 4,IRF4)是干扰素调节因子家族中的转录因子之一。在正常生理过程中,IRF4蛋白是调节早期B细胞生长、前B细胞免疫球蛋白类别转换重组、成熟B细胞体细胞超突变等B细胞生长过程的关键因子,也... 干扰素调节因子4(interferon regulatory factor 4,IRF4)是干扰素调节因子家族中的转录因子之一。在正常生理过程中,IRF4蛋白是调节早期B细胞生长、前B细胞免疫球蛋白类别转换重组、成熟B细胞体细胞超突变等B细胞生长过程的关键因子,也是调节浆细胞分化的关键因子;另一方面,Irf4基因异常或蛋白表达失调参与多种B/浆细胞肿瘤发生、发展。该文对IRF4在B/浆细胞分化成熟中的生理作用,如何参与B/浆细胞肿瘤发生发展及其作为B/浆细胞肿瘤潜在治疗靶点的研究进展进行综述。 展开更多
关键词 干扰素调节因子4 B细胞 浆细胞 淋巴瘤 白血病 骨髓瘤
原文传递
北京市垂杨柳医院患者γ-干扰素释放试验的临床应用研究 被引量:2
18
作者 王俊文 于波 +5 位作者 刘薇 高慧双 田淑琳 路璐 朱雅迪 宁永忠 《中国医药科学》 2025年第2期134-137,共4页
目的了解北京市垂杨柳医院就诊患者γ-干扰素释放试验(IGRA)检测结核分枝杆菌潜伏感染临床特征。方法收集北京市垂杨柳医院2018年1月至2022年12月的8736例患者IGRA检测结果,分析患者潜在感染状况。结果就诊患者IGRA总阳性率为17.26%(150... 目的了解北京市垂杨柳医院就诊患者γ-干扰素释放试验(IGRA)检测结核分枝杆菌潜伏感染临床特征。方法收集北京市垂杨柳医院2018年1月至2022年12月的8736例患者IGRA检测结果,分析患者潜在感染状况。结果就诊患者IGRA总阳性率为17.26%(1508/8736),2018—2022年逐年比较,差异有统计学意义(χ^(2)=13.706,P=0.008)。男性组IGRA总阳性率高于女性组,差异有统计学意义(χ^(2)=5.168,P=0.012)。4个年龄组阳性率比较,差异有统计学意义(χ^(2)=6.951,P=0.001),年龄越大IGRA阳性率越低。结论北京市垂杨柳医院就诊患者结核杆菌潜伏感染相对较高,有逐年增高趋势,提示应加强人员监测力度,提高结核分枝杆菌潜伏感染的早期诊断率。 展开更多
关键词 Γ-干扰素释放试验 潜伏结核感染 结核分枝杆菌 结核病 结核菌素皮肤试验
暂未订购
γ-干扰素诱导蛋白-10 mRNA检测技术在肺外结核病诊断中的应用
19
作者 张国英 陆忠奎 +6 位作者 王裕玲 夏厦 孟轲 何芳 黄子慧 杨增敏 刘欣 《检验医学》 2025年第4期372-376,共5页
目的 探讨基于γ-干扰素诱导蛋白-10(IP-10)mRNA的聚合酶链反应(PCR)荧光探针检测技术(即IP-10.TB)在肺外结核病诊断中的应用价值。方法 选取2023年3—10月南京中医药大学附属南京市中西医结合医院96例肺外结核病患者(结核病组)和51例... 目的 探讨基于γ-干扰素诱导蛋白-10(IP-10)mRNA的聚合酶链反应(PCR)荧光探针检测技术(即IP-10.TB)在肺外结核病诊断中的应用价值。方法 选取2023年3—10月南京中医药大学附属南京市中西医结合医院96例肺外结核病患者(结核病组)和51例非结核病变患者(非结核病组),分别进行IP-10.TB和γ-干扰素释放试验(IGRA),比较2种方法诊断肺外结核病的性能。计算IP-10.TB与Xpert MTB/RIF的符合率,比较IP-10.TB检测和IGRA不同类型肺外结核病阳性检出率的差异。结果 结核病组IP-10.TB阳性检出率(85.4%)高于非结核病组(0.0%)(χ^(2)=98.518,P<0.001)。IP-10.TB、IGRA诊断肺外结核病的敏感性和特异性差异均无统计学意义(χ^(2)值分别为3.200、0.033,P>0.05)。IP-10.TB与Xpert MTB/RIF的阳性符合率为96.3%,阴性符合率为50.0%,总符合率为89.1%。在淋巴结核和骨与关节结核这2种不同类型的肺外结核病中,IP-10.TB的阳性检出率差异无统计学意义(χ^(2)=0.156,P=0.693)。结论 IP-10.TB诊断肺外结核病敏感性高、特异性好,可用于不同类型肺外结核病的快速诊断。 展开更多
关键词 γ-干扰素诱导蛋白-10 Γ-干扰素释放试验 结核 肺外结核 诊断
暂未订购
重组鸡α干扰素对不同亚型禽流感病毒在鸡胚中感染增殖的抑制作用
20
作者 何兰 赵俊 +4 位作者 俞俊岭 罗婉蓉 周雪 方惟希 何军 《病毒学报》 北大核心 2025年第4期1105-1111,共7页
为评估重组鸡α干扰素对不同禽流感病毒在鸡胚中感染增殖的抑制作用,将重组鸡α干扰素梯度稀释为高、较高、中等、低四个不同浓度,各浓度按照“先给药再攻毒”、“同时给药和攻毒”、“先攻毒再给药”三种不同方式,对适龄SPF鸡胚进行给... 为评估重组鸡α干扰素对不同禽流感病毒在鸡胚中感染增殖的抑制作用,将重组鸡α干扰素梯度稀释为高、较高、中等、低四个不同浓度,各浓度按照“先给药再攻毒”、“同时给药和攻毒”、“先攻毒再给药”三种不同方式,对适龄SPF鸡胚进行给药和接种H10N5、H9N2、H6N6亚型禽流感病毒(AIV),同时设置药物对照和病毒对照。通过检测鸡胚尿囊液各亚型AIV凝集红细胞效价的变化,评价重组鸡α干扰素对不同亚型AIV感染和增殖的抑制效力。结果在100EID50病毒剂量下,“先给药后攻毒”方式有抑制各亚型病毒在鸡胚中感染和增殖的作用,且感染抑制比和血凝效价均随药物浓度的升高而降低,不同浓度差异具有统计学意义(P<0.01)。“同时给药和攻毒”方式对H9N2、H6N6亚型AIV感染有抑制作用,对H10N5亚型AIV感染无抑制作用,但能显著降低病毒凝集效价。“先攻毒后给药”方式均不能阻断各亚型AIV感染,但低药物浓度就能显著降低H6N6亚型AIV凝集效价(P<0.01),而H10N5亚型AIV在中等药物浓度、H9N2亚型AIV在高药物浓度中凝集效价有显著降低(P<0.05)。表明“先给药后攻毒”能在鸡胚中显著抑制H10N5、H9N2、H6N6亚型AIV感染,“同时给药和攻毒”能抑制部分感染和增殖,“先攻毒再给药”不能阻止感染,但高浓度药物亦可抑制病毒增殖。本研究为今后干扰素在预防、治疗AIV感染的应用提供了相关实验根据。 展开更多
关键词 重组鸡α干扰素 禽流感病毒 抑制作用
原文传递
上一页 1 2 250 下一页 到第
使用帮助 返回顶部